RAS effector protein (None standardized)

RAS effector proteins are a diverse group of cellular signaling mediators that interact with the GTP-bound active form of RAS GTPases. These effectors include kinases (RAF family), lipid kinases (PI3K), scaffold proteins (RASSF), and guanine nucleotide exchange factors (RALGDS), among others. Each effector binds the switch regions of RAS, transmitting signals that regulate cell proliferation, survival, differentiation, metabolism, migration, and apoptosis. In cancer and congenital disorders (RASopathies), inappropriate activation or mutation in RAS often results in aberrant signaling via these effectors. Therapies targeting RAS effectors have clinical utility in oncology, but drug resistance and pathway redundancy present significant challenges. The group “RAS effector proteins” represents multiple targets rather than a single entity and should be used with caution in structured datasets. Note: "RAS effector proteins" is a family-level classification, and for most structured biomedical needs, more precise molecular names (e.g., "RAF kinase," "PI3-kinase," "RAL guanine nucleotide dissociation stimulator," etc.) are desirable.

Other names

RAS effectorsRAS-binding proteinsRAS downstream effectorsRAFBRAFCRAFPI3KRALGDSRASSF

Inhibition of RAF/MEK/ERK kinase cascade; Inhibition of PI3K/AKT/mTOR pathway; Disruption of RAS-effector protein interactions; Targeted protein degradation (e.g., CRAF)